)
A Byron Bay-based AI platform designed to help patients stick to their physiotherapy treatment from start to finish has raised $2.1 million in a seed funding round led by Carthona Capital.
Founded in 2023 by Adam Beaupeurt and Caelum Trott, Preve is a platform that enables physiotherapists to input a diagnosis and instantly generate a tailored treatment plan, which patients can follow through automated payments while receiving recovery tracking metrics and personalised AI treatment recommendations.
During the patient’s rehabilitation, the platform tracks their progress and updates information based on the data available and the physiotherapist’s expertise.
In late 2024, the company ran a pilot focused on one part of the workflow, which Beaupeurt says “delivered excellent patient outcomes”. Since then, Preve has been co-designing the practitioner experience, now in alpha, and is gradually inviting practitioners to join ahead of a full release in the coming months.
The startup has taken a ‘modality over market’ approach to ensure global scalability and support for practitioners worldwide. While the company is registered in Byron Bay, the team is across Australia.
“Physios want their patients to get better - but our research suggests that patients drop out of care 80 per cent of the time,” Trott, who is a physiotherapist, said.
“Physios are stuck using tools that haven’t evolved in years. So, Preve lets them do more with less, providing care that’s consistent, trackable, and actually works for the modern patient.”
According to the Australian Physiotherapy Association’s 2022 whitepaper, The Future of Physiotherapy in Australia, demand for physiotherapy services continues to increase due to the ageing population, population growth and increased prevalence of chronic disease and injury.
The policy white paper also notes that the current health system leaves many people waiting too long for referrals and allied health care, often in pain or medicated on opiates.
“AI is only now reaching the point where it can genuinely help improve patient outcomes in physical therapy,” Beaupeurt said.
“By filling the gap between consultations, and coaching the patient towards positive outcomes, we’re amplifying the practitioner and their expertise.”
Other backers that participated in the seed round include Startmate, Archangel, Black Sheep Capital, Exhort Ventures, and angels such as Eucalyptus co-founders Alexey Mitko and Charlie Gearside, and EVP’s Justin Lipman.
The raise comes 10 months after Preve was part of Startmate’s Winter 2024 accelerator, alongside startups such as recruitment platform Fairgo.AI, software testing platform Bugster and maternal healthcare platform Borne.
“Preve is solving a widespread but under-discussed problem,” Carthona Capital partner Dean Dorrell said.
“We invested because they’re unlocking better outcomes for clinicians, patients and the wider health system - and doing it with empathy, insight, and precision.”
)
